Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
Abstract As a type of “cold tumor” with limited immune cell infiltration, ovarian cancer has historically shown limited efficacy in immunotherapy. In this study, we report that exosomes from ovarian cancer can specifically target omentum which is the predilection site for ovarian cancer to metastasi...
Saved in:
Main Authors: | Yuanyuan Wang, Changyi Zhang, Huimin Zeng, Liangliang Wang, Zanhong Wang, Zhiqiang Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-02-01
|
Series: | Cancer Immunology, Immunotherapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00262-025-03951-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01) -
Exosomal insights into ovarian cancer stem cells: revealing the molecular hubs
by: Kiana Sojoudi, et al.
Published: (2025-01-01) -
Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01) -
Sustained release of miR-21 carried by mesenchymal stem cell-derived exosomes from GelMA microspheres inhibits ovarian granulosa cell apoptosis in premature ovarian insufficiency
by: Xiaofei Zhang, et al.
Published: (2025-04-01) -
The Role of Exosomes in Cancer Progression and Therapy
by: Shynggys Sergazy, et al.
Published: (2025-01-01)